16/10/2000

ReGen Therapeutics strength organisation ahead of trial results and appoints Ernst and Young as nominated Adviser

30/07/2000

Interim Results for the six months to 30 June 2000

21/07/2000

Clinical Trials, Scientific and Manufacturing update

20/07/2000

AGM Statement

16/07/2000

Key Financials

16/07/2000

ReGen Therapeutics is developing a therapy for Alzheimer’s disease based on Colostrinin

23/03/2000

ReGen Therapeitics Plc public offer oversubscribed ten times. AIM Dealings start at 8AM, 24 th March

15/03/2000

ReGen Therapeutics Plc plan AIM debut on 24 March 2000

24/02/2000

Regen Therapeutics Plc complete £4.25 million placing, Public offer opens to raise £750,000 prior to move to alternative investment market (AIM)

03/02/2000

Managing Director, Joins ReGen Therapeutics from Medeva ahead of AIM Flotation

11/01/2000

Board Appointment for ReGen Therapeutics Plc